Search Results - "Swift, Mihaiela" :: K.UTB vyhledávací portál

Loading…

High Frequency of Spontaneous Helicase-Primase Inhibitor (BAY 57–1293) Drug-Resistant Variants in Certain Laboratory Isolates of HSV-1

by Biswas, Subhajit, Swift, Mihaiela, Field, Hugh J
Published in Antiviral chemistry & chemotherapy (01.04.2007)

Get full text

Journal Article

Loading…

High Frequency of Spontaneous Helicaseprimase Inhibitor (BAY 57–1293) Drug-Resistant Variants in Certain Laboratory Isolates of HSV-1

by Biswas, Subhajit, Swift, Mihaiela, Field, Hugh J
Published in Antiviral chemistry & chemotherapy (01.02.2007)

Get full text

Journal Article

Loading…

A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase–primase inhibitors in their mode of interaction with the antiviral target

by Biswas, Subhajit, Kleymann, Gerald, Swift, Mihaiela, Tiley, Laurence S., Lyall, Jonathan, Aguirre-Hernández, Jesús, Field, Hugh J.
Published in Journal of antimicrobial chemotherapy (01.05.2008)

Get full text

Journal Article

Loading…

High frequency of spontaneous helicase-primase inhibitor (BAY 57-1293) drug-resistant variants in certain laboratory isolates of HSV-1

by BISWAS, Subhajit, SWIFT, Mihaiela, FIELD, Hugh J
Published in Antiviral chemistry & chemotherapy (2007)

Get full text

Journal Article

Loading…

WITHDRAWN: Helicase-Primase Inhibitor (HPI) BAY 57-1293 can Inhibit Either HSV-1 Helicase or Primase (or Both) to Exert its Antiviral Action

by Field, Hugh, Swift, Mihaiela, Biswas, Subhajit
Published in Antiviral research (01.02.2007)

Get full text

Journal Article

High Frequency of Spontaneous Helicase-Primase Inhibitor (BAY 57–1293) Drug-Resistant Variants in Certain Laboratory Isolates of HSV-1

High Frequency of Spontaneous Helicaseprimase Inhibitor (BAY 57–1293) Drug-Resistant Variants in Certain Laboratory Isolates of HSV-1

A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase–primase inhibitors in their mode of interaction with the antiviral target

High frequency of spontaneous helicase-primase inhibitor (BAY 57-1293) drug-resistant variants in certain laboratory isolates of HSV-1

WITHDRAWN: Helicase-Primase Inhibitor (HPI) BAY 57-1293 can Inhibit Either HSV-1 Helicase or Primase (or Both) to Exert its Antiviral Action

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database